US Patent 11890272 Non-sedating dexmedetomidine treatment regimens
Patent 11890272 was granted and assigned to Bioxcel Therapeutics Inc. on February, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11890272 Non-sedating dexmedetomidine treatment regimens
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
